Endocrine side effects of immune checkpoint inhibitors

被引:17
|
作者
Cardona, Zulma [1 ]
Sosman, Jeffrey A. [2 ]
Chandra, Sunandana [2 ]
Huang, Wenyu [1 ]
机构
[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL USA
来源
关键词
immune checkpoint inhibitor (ICI); endocrine side effects; hypophysitis; thyroiditis; type1; diabetes; adrenalitis; adrenal insufficiency; central diabetes insipidus; IPILIMUMAB-INDUCED HYPOPHYSITIS; CELL LUNG-CANCER; QUALITY-OF-LIFE; ADVERSE EVENTS; RETROSPECTIVE ANALYSIS; ADRENAL INSUFFICIENCY; THYROID ANTIBODIES; PD-1; EXPRESSION; NIVOLUMAB; MANAGEMENT;
D O I
10.3389/fendo.2023.1157805
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune checkpoint inhibitors (ICIs) have increasingly been the mainstay of treatment for numerous malignancies. However, due to their association with autoimmunity, ICIs have resulted in a variety of side effects that involve multiple organs including the endocrine system. In this review article, we describe our current understanding of the autoimmune endocrinopathies as a result of the use of ICIs. We will review the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of the most commonly encountered endocrinopathies, including thyroiditis, hypophysitis, Type 1 diabetes, adrenalitis, and central diabetes insipidus.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
    Corsello, Salvatore Maria
    Barnabei, Agnese
    Marchetti, Paolo
    De Vecchis, Liana
    Salvatori, Roberto
    Torino, Francesco
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (04): : 1361 - 1375
  • [2] The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors
    Mai, Knut
    Fassnacht, Martin
    Fuehrer-Sakel, Dagmar
    Honegger, Juergen B.
    Weber, Matthias M.
    Kroiss, Matthias
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2021, 118 (23): : 389 - +
  • [3] Immune checkpoint inhibitors and endocrine side effects, a narrative review
    Agrawal, L.
    Bacal, A.
    Jain, S.
    Singh, V
    Emanuele, N.
    Emanuele, Ma
    Meah, F.
    POSTGRADUATE MEDICINE, 2020, 132 (02) : 206 - 214
  • [4] Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review
    Profili, Nicia I.
    Castelli, Roberto
    Gidaro, Antonio
    Merella, Alessandro
    Manetti, Roberto
    Palmieri, Giuseppe
    Maioli, Margherita
    Delitala, Alessandro P.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [5] Endocrine adverse effects of immune checkpoint inhibitors
    Walters, Anthony G. B.
    Braatvedt, Geoffrey
    INTERNAL MEDICINE JOURNAL, 2021, 51 (07) : 1016 - 1020
  • [6] Immune checkpoint inhibitors side effects and management
    Kourie, Hampig Raphael
    Klastersky, Jean
    IMMUNOTHERAPY, 2016, 8 (07) : 799 - 807
  • [7] Neuromuscular Side Effects of Immune Checkpoint Inhibitors
    Moreira, A.
    Loquai, C.
    Knauss, S.
    Gutzmer, R.
    Dimitriou, F.
    Meier, F.
    Heppt, M.
    Mitzel-Rink, H.
    Schuler, G.
    Terheyden, P.
    Thoms, K. M.
    Zimmer, L.
    Dummer, R.
    Pfoehler, C.
    Heinzerling, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 9 - 10
  • [8] Approval status and side effects of immune checkpoint inhibitors
    Abedin, Nada
    Waidmann, Oliver
    Trojan, Joerg
    GASTROENTEROLOGE, 2019, 14 (03): : 203 - 215
  • [9] Immune checkpoint inhibitors renal side effects and management
    El Rassy, Elie
    Kourie, Hampig R.
    Rizkallah, Jamale
    El Karak, Fadi
    Hanna, Colette
    Chelala, Dania N.
    Ghosn, Marwan
    IMMUNOTHERAPY, 2016, 8 (12) : 1417 - 1425
  • [10] Management of Gastrointestinal Side Effects of Immune Checkpoint Inhibitors
    Lui, Rashid N.
    Chan, Stephen L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (11) : 2262 - 2265